Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer ; volume:11 ; number:1 ; day:16 ; month:3 ; year:2011 ; pages:1-8 ; date:12.2011
BMC cancer ; 11, Heft 1 (16.3.2011), 1-8, 12.2011
- Urheber
-
Cellier, Patrice
- Beteiligte Personen und Organisationen
-
Leduc, Bernard
Martin, Laurent
Vié, Brigitte
Chevelle, Christian
Vendrely, Véronique
Salemkour, Augustin
Carrie, Christian
Calais, Gilles
Burtin, Pascal
Campion, Loïc
Boisdron-Celle, Michèle
Morel, Alain
Berger, Virginie
Gamelin, Erick
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-11-98
- URN
-
urn:nbn:de:1111-2016030363866
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
01.08.20252025, 05:43 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cellier, Patrice
- Leduc, Bernard
- Martin, Laurent
- Vié, Brigitte
- Chevelle, Christian
- Vendrely, Véronique
- Salemkour, Augustin
- Carrie, Christian
- Calais, Gilles
- Burtin, Pascal
- Campion, Loïc
- Boisdron-Celle, Michèle
- Morel, Alain
- Berger, Virginie
- Gamelin, Erick
- SpringerLink (Online service)
Ähnliche Objekte (12)
A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis
Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
Benefits of pre-operative concurrent chemo-radiotherapy among elder patients with local advanced rectal cancer
Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study
Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
Preoperative chemoradiotherapy using tegafur/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trial
Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer
Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer
A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis
Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
Benefits of pre-operative concurrent chemo-radiotherapy among elder patients with local advanced rectal cancer
Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study
Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
Preoperative chemoradiotherapy using tegafur/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trial
Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer
Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer
A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis
Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
Benefits of pre-operative concurrent chemo-radiotherapy among elder patients with local advanced rectal cancer
Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study
Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
Preoperative chemoradiotherapy using tegafur/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trial
Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer